- TWD4.52bn
- TWD7.22bn
- TWD1.93bn
- 19
- 19
- 95
- 40
Annual balance sheet for Bionime, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 343 | 313 | 278 | 449 | 383 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 469 | 379 | 700 | 528 | 723 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,457 | 1,390 | 1,637 | 1,617 | 1,774 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2,698 | 2,693 | 2,701 | 2,849 | 2,874 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 4,485 | 4,564 | 4,983 | 5,301 | 5,781 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,241 | 1,329 | 1,411 | 1,609 | 2,311 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 2,419 | 2,495 | 2,911 | 3,315 | 3,901 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 2,066 | 2,069 | 2,072 | 1,986 | 1,880 |
Total Liabilities & Shareholders' Equity | 4,485 | 4,564 | 4,983 | 5,301 | 5,781 |
Total Common Shares Outstanding |